» Articles » PMID: 15767425

Hepatitis B Virus X Protein Stimulates Viral Genome Replication Via a DDB1-dependent Pathway Distinct from That Leading to Cell Death

Overview
Journal J Virol
Date 2005 Mar 16
PMID 15767425
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

The hepatitis B virus (HBV) X protein (HBx) is essential for virus infection and has been implicated in the development of liver cancer associated with chronic infection. HBx can interact with a number of cellular proteins, and in cell culture, it exhibits pleiotropic activities, among which is its ability to interfere with cell viability and stimulate HBV replication. Previous work has demonstrated that HBx affects cell viability by a mechanism that requires its binding to DDB1, a highly conserved protein implicated in DNA repair and cell cycle regulation. We now show that an interaction with DDB1 is also needed for HBx to stimulate HBV genome replication. Thus, HBx point mutants defective for DDB1 binding fail to complement the low level of replication of an HBx-deficient HBV genome when provided in trans, and one such mutant regains activity when directly fused to DDB1. Furthermore, DDB1 depletion by RNA interference specifically compromises replication of wild-type HBV, indicating that HBx produced from the viral genome also functions in a DDB1-dependent fashion. We also show that HBx in association with DDB1 acts in the nucleus and stimulates HBV replication mainly by enhancing viral mRNA levels, regardless of whether the protein is expressed from the HBV genome itself or supplied in trans. Interestingly, whereas HBx induces cell death in both HepG2 and Huh-7 hepatoma cell lines, it enhances HBV replication only in HepG2 cells, suggesting that the two activities involve distinct DDB1-dependent pathways.

Citing Articles

Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence.

La Frazia S, Pauciullo S, Zulian V, Garbuglia A Viruses. 2025; 16(12.

PMID: 39772271 PMC: 11728759. DOI: 10.3390/v16121965.


SMC5/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential.

Bacher J, Allweiss L, Dandri M Viruses. 2024; 16(11).

PMID: 39599784 PMC: 11598903. DOI: 10.3390/v16111667.


Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis.

Li D, Hamadalnil Y, Tu T Viruses. 2024; 16(9).

PMID: 39339838 PMC: 11437454. DOI: 10.3390/v16091361.


Human Viral Oncoproteins and Ubiquitin-Proteasome System.

Atani Z, Hosseini S, Goudarzi H, Faghihloo E Glob Med Genet. 2024; 11(4):285-296.

PMID: 39224462 PMC: 11368560. DOI: 10.1055/s-0044-1790210.


Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH.

Gu Q, Chang Y, Jin Y, Fang J, Ji T, Lin J Hepatol Commun. 2024; 8(7).

PMID: 38934719 PMC: 11213592. DOI: 10.1097/HC9.0000000000000474.


References
1.
Xu Z, Yen T, Wu L, Madden C, Tan W, Slagle B . Enhancement of hepatitis B virus replication by its X protein in transgenic mice. J Virol. 2002; 76(5):2579-84. PMC: 153824. DOI: 10.1128/jvi.76.5.2579-2584.2002. View

2.
Lee H, Lee Y, Huh Y, Moon H, Yun Y . X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem. 1995; 270(52):31405-12. DOI: 10.1074/jbc.270.52.31405. View

3.
Liu C, Powell K, Mundt K, Wu L, Carr A, Caspari T . Cop9/signalosome subunits and Pcu4 regulate ribonucleotide reductase by both checkpoint-dependent and -independent mechanisms. Genes Dev. 2003; 17(9):1130-40. PMC: 196048. DOI: 10.1101/gad.1090803. View

4.
Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Drapkin R . The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell. 2003; 113(3):357-67. DOI: 10.1016/s0092-8674(03)00316-7. View

5.
Leupin O, Bontron S, Strubin M . Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol. 2003; 77(11):6274-83. PMC: 154990. DOI: 10.1128/jvi.77.11.6274-6283.2003. View